Expansion of Prehabilitation Program: The Newcastle model of prehabilitation care for cancer patients will be expanded to five rural and regional locations in New South Wales, aiming to improve survival and quality of life for patients before surgery.
Study and Funding: The program, led by Dr. Jennifer Mackney, has received an $800,000 Cancer Institute NSW Accelerated Research Implementation Grant to test the effectiveness and implementation of the prehabilitation model in regional communities.
Impact and Accessibility: The prehabilitation program, which includes exercise, nutrition, and psychological support, has been shown to improve cancer survivorship and reduce surgical complications. The expansion aims to improve access to these services, particularly in underserved rural and regional areas.
A Newcastle model of prehabilitation care for cancer patients prior to surgery, which aims to increase survival and improve quality of life, will be expanded to five rural and regional locations.
The project, led by Dr Jennifer Mackney, a John Hunter Hospital based clinical specialist physiotherapist and researcher with the University of Newcastle and HMRI has been awarded an $800,000 Cancer Institute NSW Accelerated Research Implementation Grant.
The effectiveness and implementation study will test the upscaling of the Newcastle prehabilitation model of care in five regional communities.
Hospital-based surgery is essential in cancer care. In Australia each year, it is estimated 165,000 people will be diagnosed with cancer. Around 132,000 of these people will require surgery, often multiple times.
Prehabilitation is an intervention program that helps people prepare for cancer treatment by improving their physical and mental health. It can include exercise, nutrition optimisation, and psychological support before surgery, helping people to recover faster, reduce the risk of complications, and feel more in control of their health.
Dr Mackney said prehabilitation had been shown to improve cancer survivorship and quality of life.
โPhysical fitness and wellbeing are critical for better surgical outcomes. However, cancer and its treatments often impact physical activity, nutrition, and overall fitness, which can increase the risk of poor surgical outcomes,โ she said.
Dr Mackney said multimodal prehabilitation before cancer surgery had been shown to improve cancer
patientsโ physical function, halved postoperative complications and reduced postoperative hospital length of stay.
โHowever, access to formal multimodal prehabilitation programs in Australia is generally poor and people with cancer in regional and rural NSW experience an even greater disadvantage in accessing these programs.โ
The Newcastle program is known as โC-SPRITES โ Improving equity of access to prehabilitation services in
regional and rural NSW: Supported Prehabilitation โ Improving fitness, ensuring well-being before surgery in people living with cancerโ.
โThis grant builds on work previously funded through the NSW Regional Cancer Research Network and will enable our research team to implement the C-SPRITES hybrid model of care within the regional and rural participant communities. It will be delivered by health providers in-person and via the Newcastle-based team using telehealth.
โOur aim is to improve access to multimodal prehabilitation services for patients with cancer who are living in rural and regional areas and assess the programโs effectiveness and acceptability for patients, hospitals, referrers and community partners.
This important medical research demonstrates the Universityโs commitment to helping its communities live better, healthier lives.
HMRI would like to acknowledge the Traditional Custodians of the land on which we work and live, the Awabakal and Worimi peoples, and pay our respects to Elders past and present. We recognise and respect their cultural heritage and beliefs and their continued connection to their land.
Hunter Medical Research Institute
Weโre taking healthy further.
Locked Bag 1000
New Lambton
NSW, Australia, 2305
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright ยฉ 2024 Hunter Medical Research Institute | ABN: 27 081 436 919
Site by Marlin Communications